At Molecular Diagnostics and Therapy, the right investigations are carried out to support the assessment of thyroid-related conditions. This article discusses the thyroglobulin test for thyroid cancer, its purpose, the factors that influence the outcome, and its importance in managing the disease.
What Is a Thyroglobulin Test?
Thyroglobulin (Tg) is a protein made by normal thyroid cells and
most differentiated thyroid cancer cells. A thyroglobulin test checks blood for
this protein. This test is primarily used to check patients who have been
treated for differentiated thyroid cancers, such as papillary and follicular
thyroid cancer. Following a total or near-total thyroidectomy, thyroglobulin
levels should be very low or undetectable in the majority of patients.
Finding thyroglobulin in the blood indicates that there might be
some amount of normal thyroid tissue or cancer left in the body, with a few
exceptions. A thyroglobulin test is not used for screening for thyroid cancer.
This test should not be used as a first-line test to evaluate a suspicious
thyroid nodule for malignancy. Instead, it is used to track patients who have
already been treated for thyroid cancer, and it does not apply to all patients
with thyroid cancer, depending on the type and treatment they have received.
Why Is the Thyroglobulin Test Important in
Thyroid Cancer?
The thyroglobulin test result is always interpreted in the context
of the individual patient, including their treatment history. It is considered
an effective method of determining the likelihood of malignancy in thyroid
nodules, depending on the type of cancer, the treatment course, and the amount
of remaining thyroid tissue.
1. Monitoring Treatment Response
After surgery and/or radioactive iodine ablation, the
thyroglobulin test may be used to determine the response to the treatment
course. A low or undetectable thyroglobulin level is a reassuring sign,
suggesting that the treatment has been successful, especially if it is combined
with other investigations. It is vital to realise that the expected level of
thyroglobulin depends on the type of surgery that the patient has undergone,
whether they have received radioactive iodine therapy, and the treatment course
that they are on.
2. Detecting Possible Cancer Recurrence
Although cancer treatment can be very successful, thyroid cancer
can often recur after treatment. A rise in thyroglobulin levels may indicate
the presence of cancer cells, which means that the doctor may want to carry out
more extensive investigations, such as a neck ultrasound. A rising
thyroglobulin level does not necessarily indicate cancer; it should always be
interpreted in the context of the patient’s treatment history and other
laboratory and imaging results.
3. Supporting Long-Term Follow-Up
There are extensive follow-up treatment processes for people who
have had thyroid cancer, depending on the nature of their cancer and the
treatment they received. Regular thyroglobulin tests enable physicians to
identify whether the amount of protein is increasing or decreasing over time,
which can be incredibly valuable in determining whether additional investigations
are necessary. The frequency of tests and the time interval between them will
be determined by the type of cancer and therapy that the patient has had.
Thyroglobulin tests are performed every 6-12 months for many patients following
initial therapy for the first few years, with some patients requiring more
regular tests.
How Is the Thyroglobulin Test Performed?
The thyroglobulin test is performed by drawing blood from a vein
in the patient’s arm. The sample is then forwarded to the laboratory for
processing. The test itself is fast and simple and only causes the patient
minimal discomfort. The thyroglobulin test does not require the patient to fast
before coming in for it, but they might have to follow certain protocols before
the procedure. The doctor might also suggest the TSH blood test and
anti-thyroglobulin antibody test in addition to the thyroglobulin test. These
tests, when taken together with the thyroglobulin test, can aid in determining
the likelihood of cancer recurrence.
The most specific test for detecting differentiated thyroid cancer
is the thyroglobulin test; however, the results of this test should always be
examined in conjunction with the patient’s treatment history and other tests,
such as an ultrasound. Ideally, the same lab and thyroglobulin assay should be
used each time. The results might differ from one assay to another.
What Do Thyroglobulin Test Results Mean?
It is impossible to give a reference range that applies to all
patients with thyroid cancer. Rather, the expected result depends on whether
the patient has undergone total thyroidectomy or subtotal thyroidectomy, had
RAI ablation, and is on thyroid hormone treatment or TSH stimulation. If the
patient has had a total thyroidectomy and RAI ablation, they will most likely
have very low or undetectable thyroglobulin levels. This suggests that the
treatment was successful but does not rule out the possibility of recurrence.
If the patient has had a subtotal thyroidectomy, they may have
higher thyroglobulin levels after treatment because some normal thyroid tissue
remains. A gradual increase in thyroglobulin levels over several tests suggests
that something is happening that requires further investigation, most likely in
patients who have been treated for differentiated thyroid cancer. The doctor
will consider the entire clinical picture when interpreting the results of a
thyroglobulin test. An abnormal test result, when combined with abnormal
findings from imaging tests, may suggest that the cancer has recurred, and
further testing is required.
What Is the Role of Anti-Thyroglobulin
Antibodies?
Abnormal thyroid function can lead to the production of
autoantibodies against thyroglobulin. In some cases, these antibodies can cause
the thyroglobulin test to give falsely low results. Because of this, the TgAb
test is also performed along with the thyroglobulin test in thyroid cancer
follow-up patients. If anti-thyroglobulin antibodies are detected, their
presence may need to be monitored over time.
Antibody levels typically remain the same or decrease, but
increasing levels may be a warning sign. A doctor may also perform an
ultrasound or other imaging technique to determine whether abnormal levels of
thyroglobulin are due to remaining thyroid tissue or cancer. Anti-thyroglobulin
tests are not used to diagnose cancer; rather, they are a method of monitoring
the condition.
Who May Need a Thyroglobulin Test?
This test is primarily used in patients who have been treated for
differentiated thyroid cancer. It may be used to determine a baseline value
after treatment, to monitor the response to treatment, and to look for signs of
recurrence. The thyroglobulin test may not be used in patients who have had a
large proportion of their thyroid gland removed or those who have non-cancerous
enlargement of the thyroid gland, as well as those with hypothyroidism or
hyperthyroidism or a new thyroid nodule.
These patients will have different tests to help in their
diagnosis. The thyroglobulin test is not given to everyone who has
thyroid-related problems; rather, it is given based on the recommendations of
the doctor, depending on the patient’s needs. Patients who suspect that they
have thyroid cancer should speak with their doctor to determine the most
appropriate treatment and the tests they will need to undergo.
Thyroglobulin Testing at Molecular Diagnostics
and Therapy
Patients with differentiated thyroid cancer often require
long-term treatment and follow-up, and the thyroglobulin test is an essential
component of this care. At Molecular Diagnostics and Therapy, the appropriate
investigations are chosen for each patient to help manage their disease.
Patients should speak with Dr. Nikunj Jain, Co-Founder and Head of Nuclear
Medicine at Molecular Diagnostics and Therapy, about the tests that they need
and the frequency with which they should be completed.
Dr. Nikunj Jain, a nuclear medicine specialist, can advise
patients on the tests that they may need, including any nuclear medicine
investigations, such as radioactive iodine imaging, if indicated. The type of
investigation performed will depend on the doctor’s assessment, the patient’s
symptoms, and their treatment history.
Conclusion
The thyroglobulin test is used in patients who have been treated
for differentiated thyroid cancer to determine how well the treatment is
working and to see if the cancer is returning. However, the test results can’t
be interpreted in a vacuum; they must be evaluated in the context of the
antibody levels, treatment history, and any imaging results. Dr. Nikunj Jain at
Molecular Diagnostics and Therapy goes above and beyond to ensure that patients
receive the care that they require. The patient should always follow the advice
of a specialist regarding the tests that they require to manage their thyroid
cancer.